收费全文 | 1360247篇 |
免费 | 85565篇 |
国内免费 | 2967篇 |
耳鼻咽喉 | 16685篇 |
儿科学 | 46668篇 |
妇产科学 | 35309篇 |
基础医学 | 188891篇 |
口腔科学 | 33931篇 |
临床医学 | 117604篇 |
内科学 | 266512篇 |
皮肤病学 | 28756篇 |
神经病学 | 112269篇 |
特种医学 | 52610篇 |
外国民族医学 | 385篇 |
外科学 | 201170篇 |
综合类 | 26820篇 |
一般理论 | 444篇 |
预防医学 | 112772篇 |
眼科学 | 29218篇 |
药学 | 94594篇 |
23篇 | |
中国医学 | 3277篇 |
肿瘤学 | 80841篇 |
2021年 | 10179篇 |
2019年 | 10791篇 |
2018年 | 37121篇 |
2017年 | 28166篇 |
2016年 | 31393篇 |
2015年 | 16233篇 |
2014年 | 20110篇 |
2013年 | 30767篇 |
2012年 | 49497篇 |
2011年 | 64201篇 |
2010年 | 42580篇 |
2009年 | 33148篇 |
2008年 | 58722篇 |
2007年 | 63265篇 |
2006年 | 43438篇 |
2005年 | 43519篇 |
2004年 | 43139篇 |
2003年 | 41996篇 |
2002年 | 38597篇 |
2001年 | 51847篇 |
2000年 | 53206篇 |
1999年 | 44659篇 |
1998年 | 12090篇 |
1997年 | 10872篇 |
1996年 | 10782篇 |
1995年 | 10373篇 |
1994年 | 9645篇 |
1993年 | 8948篇 |
1992年 | 34751篇 |
1991年 | 33745篇 |
1990年 | 33225篇 |
1989年 | 31859篇 |
1988年 | 29076篇 |
1987年 | 29073篇 |
1986年 | 27136篇 |
1985年 | 26132篇 |
1984年 | 19508篇 |
1983年 | 16451篇 |
1982年 | 9848篇 |
1979年 | 17845篇 |
1978年 | 12911篇 |
1977年 | 10961篇 |
1976年 | 10286篇 |
1975年 | 10835篇 |
1974年 | 13167篇 |
1973年 | 12679篇 |
1972年 | 11658篇 |
1971年 | 10883篇 |
1970年 | 10139篇 |
1969年 | 9526篇 |
Introduction
There is an urgent need for new anti-tuberculosis (TB) drugs and optimization of current TB treatment. Moxifloxacin and linezolid are valuable options for the treatment of drug-resistant TB; however, it is crucial to find a dose at which these drugs not only show high efficacy but also suppress the development of further drug resistance.Methods
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis was studied in the hollow-fiber infection model system in log-phase growth under neutral pH and slow growth in an acidic environment. Doses that achieved maximum bacterial kill while suppressing the emergence of drug resistance were determined. Through Monte Carlo simulations the quantitative output of this in vitro study was bridged to the human patient population to inform optimal dosage regimens while accounting for clinical minimum inhibitory concentration (MIC) distributions.Results and Discussion
Moxifloxacin activity was significantly decreased in an acidified environment. The loss of activity was compensated by accumulation of the drug in TB lung lesions; therefore, moderate efficacy can be expected. Moxifloxacin 800 mg/day is the dose that most likely leads to resistance suppression while exerting maximum bacterial kill. Linezolid demonstrated very good activity even at a reduced pH. Linezolid 900 mg once-daily (QD) is likely to achieve a maximum killing effect and prevent the emergence of drug resistance; 600 mg QD in a robust drug regimen may have similar potential. 相似文献Methods: Attributes were defined from a literature search, clinician and patient interviews: shape, dose insertion, dose preparation, dose release, dose confirmation, dose counter and reusability. An online DCE was conducted in respondents with self-reported COPD stage 2–4 recruited through a panel. The study questionnaire included twelve choice scenarios per respondent and questions on patient characteristics, treatment and disease severity. Statistical analyses used a mixed logit regression model with random effects. Utility scores were estimated for four types of inhalers: Inhaler A – soft mist inhaler; Inhaler B – reusable soft mist inhaler; Inhaler C – multi-dose dry powder inhaler; and Inhaler D – single dose dry powder inhaler.
Results: The study was completed by 153 patients (50 females); respondents were 50.4?years old on average; 13 different inhaler devices were reported. The most preferred inhaler is L-shaped, has dose preparation with capsule insertion and a dose counter, and is reusable. Inhaler profiles A and B had the highest utilities (mean of 1.2533 and 0.9578 respectively) compared to inhaler C (0.6315) and D (0.2200).
Conclusions: This study showed statistically significant results that the strongest drivers of preference in French users of inhalation devices for COPD are shape, dose counter and reusability. Convenience-related characteristics are important to patients and should be taken into account by clinicians prescribing these devices. 相似文献
Purpose
The purpose of this study was to assess the potential of a deep learning model to discriminate between benign and malignant breast lesions using magnetic resonance imaging (MRI) and characterize different histological subtypes of breast lesions.Materials and methods
We developed a deep learning model that simultaneously learns to detect lesions and characterize them. We created a lesion-characterization model based on a single two-dimensional T1-weighted fat suppressed MR image obtained after intravenous administration of a gadolinium chelate selected by radiologists. The data included 335 MR images from 335 patients, representing 17 different histological subtypes of breast lesions grouped into four categories (mammary gland, benign lesions, invasive ductal carcinoma and other malignant lesions). Algorithm performance was evaluated on an independent test set of 168 MR images using weighted sums of the area under the curve (AUC) scores.Results
We obtained a cross-validation score of 0.817 weighted average receiver operating characteristic (ROC)-AUC on the training set computed as the mean of three-shuffle three-fold cross-validation. Our model reached a weighted mean AUC of 0.816 on the independent challenge test set.Conclusion
This study shows good performance of a supervised-attention model with deep learning for breast MRI. This method should be validated on a larger and independent cohort. 相似文献Rotavirus (RV) is the most common cause of acute gastroenteritis in children <5 years of age worldwide, and vaccination reduces the disease burden. Evidence from postmarketing surveillance studies suggested an increased risk of intussusception (IS) in infants post-RV vaccination. An overall positive benefit–risk balance for the human RV vaccine (HRV) Rotarix (GlaxoSmithKline [GSK], Belgium) has been established and recent findings indicate an indirect effect of reduced IS over the long term.
ObjectiveThe aim of this study was to discuss spontaneous data from the GSK worldwide safety database on IS post-Rotarix administration.
MethodsThe database was reviewed for all spontaneous IS cases from 2004 to 2020. Additionally, an observed versus expected (O/E) analysis was done for adverse events attributed to IS. Data were reviewed as overall worldwide and stratified by region (Europe/USA/Japan) and dose.
ResultsA male predominance of IS patients was observed, consistent with earlier reports. The most frequently reported events in confirmed IS cases (Brighton Collaboration Working Group [BCWG] level 1) with time to onset ≤ 30 days post-vaccination were vomiting (55.8%), haematochezia (47.2%), and crying (21.1%). The observations from the IS spontaneous cases review and results of the O/E analysis are consistent with the known IS safety profile of RV vaccines: a transient increased incidence of IS post-vaccination (primarily in Europe/Japan/worldwide), mostly within 7 days postdose 1.
ConclusionSince the outcomes of early IS management are favourable over delayed management, healthcare professionals should inform parents about the importance of seeking immediate medical advice in case of unusual behaviour of the vaccinated infant. GSK continues to monitor the IS risk post-Rotarix administration through routine pharmacovigilance activities.
Graphic abstract 相似文献